From 9 till 12 September 2023: HIGHLIGHTS ON LUNG CANCER

Your direct line with Singapore

The World Conference on Lung Cancer 2023 brings together leading experts in the field of lung cancer from around the world. And, this year they gather together in Singapore. The MediMix team is also onsite, and will – together with your Belgian colleagues – keep you posted about the hottest topics as they happen. And, we dive into posters and hot topics with the experts as they are being presented.

Stay tuned, and get ready for an exciting and informative journey!

With the educational support of

Daily highlights

Immunotherapy in ES-SCLC and advanced NSCLC

Dr Eleni Xenophontos, a medical oncologist and clinical research physician at the European Organisation for Research and Treatment of Cancer (EORTC) in Brussels, kindly summarised the recent updates on immunotherapy presented at WCLC.
In her presentation, she discussed the five-year

See video »

Updates in lung cancer screening

Prof Annemiek Snoeckx from the University Hospital in Antwerp presented the latest updates on screening at WCLC. One of the main topics that received a lot of attention was recruiting participants in screening trials. Unlike European studies, the meeting mainly

See video »

In-depth stories

The Destiny-Lung02 study

Prof dr Pasi Jänne, medical oncologist at the Dana Farber Cancer Institute, Boston, MA, USA presented the primary results of the DESTINY-Lung02 study evaluating 2 doses of trastuzumab deruxtecan (T-DXd) in patients with HER2-mutant metastatic non-small cell lung cancer

See video »

The FLAURA2 study

Prof dr Pasi Jänne, medical oncologist at the Dana Farber Cancer Institute, Boston, MA, USA presented the outcomes of the FLAURA study during the presidential symposium at WCLC. FLAURA2 is a global, phase III, open-label, randomized study evaluating the

See video »

Surgery for mesothelioma

Prof dr Paul Van Schil, thoracic surgeon from Antwerp University Hospital and the new president of IASLC, took the time for an interview about the role of surgery for mesothelioma. He dives into the results of the EORTC 1205 study,

See video »

Defining oligoprogression in NSCLC

During an educational session at WCLC, Prof Dr Yolande Lievens, a radiation oncologist from Ghent University, gave a presentation on the topic of oligoprogression. She began by explaining that there is no clear agreement on the definition of oligoprogression and

See video »

Update of the pivotal phase 1/2 TRIDENT-1 trial

During a recent update of the TRIDENT-1 trial, Prof Dr Byoung Chul Cho, a medical oncologist at Yonsei Cancer Center in Seoul, South Korea, presented positive results for repotrectinib, a next-generation ROS1 tyrosine kinase inhibitor (TKI) in patients with locally

See video »

Pulmonary rehabilitation in NSCLC

Sarah Haesevoets is a PhD student at Hasselt University, and she works as a physiotherapist clinician-researcher at hospitals in Hasselt (Jessa Ziekenhuis) and Genk (Ziekenhuis Oost-Limburg). Her research focuses on physical activity for patients with lung cancer, and she recently

See video »

Poster selection

Z1. Researchpark 30, 1731 Zellik, Belgium
Website created by MediMix © 2023 - Privacy Policy